TZD

DRUG2 trials

Sponsors

China Medical University Hospital, Sanofi

Conditions

Type 2 Diabetes MellitusType 2 Diabetes Mellitus With Features of Insulin Resistance

Phase 2

Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy

CompletedNCT01577095

China Medical University HospitalType 2 Diabetes Mellitus With Features of Insulin Resistance

Start: 2006-04-30End: 2007-05-31Updated: 2012-04-13

Phase 3

Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes

CompletedNCT01940965

SanofiType 2 Diabetes Mellitus

Start: 2013-09-30End: 2015-07-31Updated: 2015-08-04

Related Papers

Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open-label, multicenter study.

2017-06-124 citations

Electroacupuncture and rosiglitazone combined therapy as a means of treating insulin resistance and type 2 diabetes mellitus: a randomized controlled trial.

2013-07-2920 citations